Abansado, Daisy Joy .

HRN: 07-47-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
CEFUROXIME 500MG (TAB)
12/14/2023
12/21/2023
PO
500 Mg
BiD
2nd Degree RMLE
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: